Ping Chen
Impact in
- Cancer Research top 5%
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Cancer, Hypoxia, and Metabolism 6
-
- Ubiquitin and proteasome pathways 10
- PI3K/AKT/mTOR signaling in cancer 6
- Protein Kinase Regulation and GTPase Signaling 5
- Co-authors
- Simon Bergqvist (4 shared papers)James Register (4 shared papers)Tao Hu (13 shared papers)Rose Ann Ferre (2 shared papers)Zhuqing Jia (3 shared papers)Chunyan Zhou (3 shared papers)Kangtao Ma (3 shared papers)Chen‐Chen Kan (2 shared papers)
- Journals
- Cell Death and Disease (4 papers)Oncotarget (4 papers)Journal of Medicinal Chemistry (4 papers)APOPTOSIS (3 papers)Biochemistry (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ping Chen
119 papers receiving 4.5k citations
Ping Chen's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 488
- Hematology 399
- Oncology 525
- Molecular Biology 1.4k
- Computational Theory and Mathematics 325
Countries citing papers authored by Ping Chen
This map shows the geographic impact of Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Chen more than expected).
Fields of papers citing papers by Ping Chen
This network shows the impact of papers produced by Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Chen. The network helps show where Ping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of N -(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays Hit paper breakdown → | 2004 | 1141 |
| 2 | Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance Hit paper breakdown → | 2016 | 363 |
| 3 | 2008 | 185 | |
| 4 | 2000 | 171 | |
| 5 | 2019 | 146 | |
| 6 | 1996 | 132 | |
| 7 | 2002 | 126 | |
| 8 | 2014 | 106 | |
| 9 | 2018 | 93 | |
| 10 | 2011 | 77 | |
| 11 | 2017 | 69 | |
| 12 | 2012 | 68 | |
| 13 | 2017 | 67 | |
| 14 | 2015 | 66 | |
| 15 | 1995 | 65 | |
| 16 | 2010 | 59 | |
| 17 | 2016 | 59 | |
| 18 | 2018 | 59 | |
| 19 | 2015 | 57 | |
| 20 | 2019 | 57 |
About Ping Chen
Ping Chen is a scholar working on Cancer Research, Molecular Biology, Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 126 papers that have together received 4.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Esophageal Cancer Research and Treatment (7 papers), Photodynamic Therapy Research Studies (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer-related Molecular Pathways (6 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). The work is most often cited by research in Cancer Research (488 citations), Hematology (399 citations), Oncology (525 citations), Molecular Biology (1.4k citations) and Computational Theory and Mathematics (325 citations). Ping Chen has collaborated with scholars based in China, United States and France. Frequent co-authors include Simon Bergqvist, James Register, Tao Hu, Rose Ann Ferre, Zhuqing Jia, Chunyan Zhou, Kangtao Ma, Chen‐Chen Kan, Stephen A. Margosiak and Wenyue Hu. Their work appears in journals such as Cell Death and Disease, Oncotarget, Journal of Medicinal Chemistry, APOPTOSIS and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.